Evidence map›Paper›PMID 35261787›Full record

ArticleAmerican journal of cancer research2022

Recombinant cell-detecting RaDR-GFP in mice reveals an association between genomic instability and radiation-induced-thymic lymphoma.

Akira Fujimori, Hirokazu Hirakawa, Cuihua Liu, Taishin Akiyama, Bevin P Engelward, Jac A Nickoloff, Masao Suzuki, Bing Wang, Mitsuru Nenoi, Sei Sai

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Akira FujimoriDepartment of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST) Chiba 263-8555, Japan.
Hirokazu HirakawaDepartment of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST) Chiba 263-8555, Japan.
Cuihua LiuDepartment of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST) Chiba 263-8555, Japan.
Taishin AkiyamaLaboratory for Immune Homeostasis, RIKEN Center for Integrative Medical Sciences Yokohama 230-0045, Japan.
Bevin P EngelwardDepartment of Biological Engineering, Massachusetts Institute of Technology Cambridge, MA 02139, USA.
Jac A NickoloffDepartment of Environmental and Radiological Health Sciences, Colorado State University Fort Collins, CO 80523, USA.
Masao SuzukiDepartment of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST) Chiba 263-8555, Japan.
Bing WangDepartment of Radiation Effects Research, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology (QST) Chiba 263-8555, Japan.
Mitsuru NenoiHuman Resources Development Center, National Institutes for Quantum Science and Technology Chiba 263-8555, Japan.
Sei SaiDepartment of Charged Particle Therapy Research, Institute of Quantum Medical Science (QMS), National Institutes for Quantum Science and Technology (QST) Chiba 263-8555, Japan.
National Institutes for Quantum Science and Technology · JPColorado State University · USMassachusetts Institute of Technology · USRIKEN Center for Integrative Medical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we aimed to investigate how homologous recombinant (HR)-related genomic instability is involved in ionizing radiation (IR)-induced thymic lymphoma in mice. We divided five-week-old Rosa26 Direct Repeat-GFP (RaDR-GFP) transgenic mice into non-IR control and IR groups and exposed the mice in the IR group to a 7.2 Gy dose of γ-rays, delivered in 1.8 Gy fractions, once a week for four weeks. We then estimated mouse survival and recorded their body, thymus, and spleen weights. The frequency of HR events in the chromosomes of the thymus, bone marrow, and spleen cells and the phenotype of thymic lymphoma cells were analyzed using fluorescence-activated cell sorting (FACS). We found that most mice in the IR group developed thymic lymphoma, their survival rate decreasing to 20% after 180 days of IR exposure, whereas no mice died in the non-IR control group until day 400. The thymus and spleen weighed significantly more in the IR-4-month group than that in the non-IR group; however, we observed no significant differences between the body weights of the control and IR mice. FACS analysis indicated that the frequency of HR events significantly increased at two and four months after the last IR dose in the bone marrow and thymus cells, but not in the spleen cells of RaDR-GFP transgenic mice, suggesting that recombinant cells accumulated in the thymus upon IR exposure. This suggests that IR induces genome instability, revealed as increased HR, that drives the development of thymic lymphoma. Additionally, phenotypic analysis of lymphoma cells showed an increase in the CD4

Indexed as

genome instabilityhomologous recombination (replication stress)lymphomaRadiation

Identifiers

PMID35261787
PMCPMC8899999
OpenAlexW4226490173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.